Key points are not available for this paper at this time.
Advancements in exosome engineering denote auspicious alternatives to conventional cancer therapies, with benefits like reduced toxicity and enhanced targeting. Understanding the biology of TDEs implements the development of novel treatments and improves diagnostics, prognostics, and monitoring of cancer progression. Integrating TDE-based tools with personalized medicine credits the potential to transform cancer care by providing more effective and individualized therapies.
Javdani-Mallak et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: